Leadership Overview
Penumbra has 5 executives leading key functions including strategy, finance, information technology, medical affairs, and international operations.
Driven by innovation, Penumbra is dedicated to advancing neurovascular and neurosurgical care through groundbreaking medical devices, aiming to significantly improve patient outcomes and expand treatment accessibility globally.
Driven by innovation, Penumbra is dedicated to advancing neurovascular and neurosurgical care through groundbreaking medical devices, aiming to significantly improve patient outcomes and expand treatment accessibility globally.
Leadership Roles at Penumbra
Adam Elsesser - Chairman & Chief Executive Officer
Adam Elsesser, the Chairman & Chief Executive Officer at Penumbra, directs the company's overarching strategy and operational execution. Overseeing all facets of the business, Elsesser ensures Penumbra's continued leadership in designing, developing, and marketing advanced medical devices for neurovascular and neurosurgical applications. This leadership role involves guiding product innovation, expanding market reach across the United States, Europe, Canada, Australia, and Japan, and fostering a culture of relentless improvement. By championing the development of aspiration-based thrombectomy systems and neurovascular access solutions, Adam Elsesser drives the company's mission to improve patient outcomes and enhance treatment accessibility worldwide. The Chairman & Chief Executive Officer's strategic vision directly impacts Penumbra's financial performance and its position as an industry innovator.

Maggie Yuen - Chief Financial Officer
Maggie Yuen, the Chief Financial Officer at Penumbra, manages all financial operations and strategic financial planning. Overseeing fiscal health, Yuen ensures robust financial controls and drives resource allocation to support Penumbra's global expansion and product development initiatives. This critical role involves managing investor relations, optimizing capital structure, and providing financial insights to guide executive decision-making. By meticulously analyzing market trends and financial performance, Maggie Yuen supports the company's growth objectives in neurovascular access systems and thrombectomy devices. The Chief Financial Officer's expertise is essential for maintaining financial stability and enabling Penumbra's continued innovation across its international markets.
James Pray - President, International
James Pray, the President, International at Penumbra, spearheads the company's strategic expansion and operational management across global markets. Overseeing all business activities outside the United States, Pray drives revenue growth and market penetration for Penumbra's innovative medical devices. This leadership position involves developing and executing region-specific strategies, managing international sales teams, and ensuring compliance with diverse regulatory environments in Europe, Canada, Australia, and Japan. By fostering strong relationships with international partners and healthcare providers, James Pray enhances Penumbra's global footprint. The President, International's focus on market dynamics and customer needs is essential for Penumbra's sustained worldwide success.

Pankaj Tiwari - Executive Vice President & Chief Information Officer
Pankaj Tiwari, the Executive Vice President & Chief Information Officer at Penumbra, architects the company's technology infrastructure and digital strategy. Overseeing all IT operations, Tiwari ensures the secure and efficient deployment of systems that support Penumbra's global manufacturing, research, and commercial activities. This leadership position involves driving digital transformation initiatives, enhancing cybersecurity measures, and leveraging data analytics to optimize business processes. By implementing cutting-edge technological solutions, Pankaj Tiwari enables seamless collaboration and operational efficiency across the company's international presence. The Executive Vice President & Chief Information Officer's focus on technological advancement is crucial for Penumbra's ongoing success in the competitive medical device market.

James Benenati - Chief Medical Officer
James Benenati, the Chief Medical Officer at Penumbra, provides critical clinical insights and guidance for the company's medical device portfolio. Overseeing clinical strategy and medical affairs, Benenati ensures that Penumbra's neurovascular and thrombectomy systems meet the highest standards of patient safety and efficacy. This role involves collaborating with healthcare professionals worldwide to gather feedback, inform product development, and support clinical research initiatives. By bridging the gap between medical needs and technological innovation, James Benenati directly contributes to the advancement of patient care. The Chief Medical Officer's expertise is vital for validating the clinical utility and market adoption of Penumbra's groundbreaking devices.
Explore Leadership Teams in Manufacturing
Founded in 1919, Ottobock is a German family-owned prosthetics company that provides medical technology solutions. Products include lightweight, active, and power wheelchairs, pediatric rehabilitation products, and seating shell systems. Otto Bock also offers polyurethane foams, foam systems for the automotive industry, and information and communication technology. The company is headquartered in Duderstadt, Germany.
Company Leadership KO
SB
TB
SH
EssilorLuxottica is a global vision care and eyewear company that designs, manufactures, distributes, and sells ophthalmic lenses, optical equipment, prescription eyewear, sunglasses, and advanced wearable technologies. The organization was formed through the combination of Essilor, a global leader in ophthalmic lenses and optical technologies, and Luxottica, one of the world's largest eyewear manufacturers and retailers. Since its creation, the company has become the largest vertically integrated participant in the global vision care industry. The organization operates across the full vision care value chain, encompassing research, product development, manufacturing, wholesale distribution, retail operations, vision insurance services, and digital commerce. This integrated structure enables the company to maintain control over product innovation, manufacturing quality, consumer experience, and distribution efficiency. By combining expertise in both eye-care technology and eyewear fashion, EssilorLuxottica serves consumers, healthcare professionals, retailers, and institutions around the world.
Company Leadership SR
AH
Edwards Lifesciences is a global medical technology company focused on developing innovative solutions for structural heart disease and critical care monitoring. The company is dedicated to improving patient outcomes through advanced technologies, clinical research, and close collaboration with healthcare professionals. Its mission centers on delivering life-changing therapies that address serious cardiovascular conditions, particularly those involving the hearts valves and structural components.
Company Leadership
HG
MO
GS
Founded in 1968, Novanta together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Lincoln Laser, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change. Novanta is a trusted technology partner to medical and advanced industrial OEMs (original equipment manufacturers), with deep proprietary expertise in photonics, vision and precision motion technologies. We engineer mission-critical core components and subsystems that deliver extreme precision and performance, enabling our customers to improve productivity, achieve breakthrough performance and enhance peoples lives. The company is headquartered in Bedford, Massachusetts.
Company Leadership LW

JL
